欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
DE/H/5051/002
药品名称
Memantinhydrochlorid-neuraxpharm 10 mg Schmelztabletten
活性成分
memantine hydrochloride 10.0 mg
剂型
Orodispersible tablet
上市许可持有人
neuraxpharm Arzneimittel GmbH Elisabeth-Selbert-Str. 23 D-40764 Langenfeld
参考成员国 - 产品名称
Germany (DE)
互认成员国 - 产品名称
许可日期
2013/09/05
最近更新日期
2020/01/29
药物ATC编码
N06DX01 memantine
申请类型
TypeLevel1：
[not specified]
TypeLevel2：
[not specified]
TypeLevel3：
[not specified]
TypeLevel4：
[not specified]
TypeLevel5：
[not specified]
附件文件下载
PAR
|
PAREN-DE 5051_Memantin
Date of last change:2017/09/22
Final Labelling
|
DE_3650_Memantin Aristo_bl_fct_20170907_renewal
Date of last change:2017/09/07
Final Labelling
|
DE_5051_Memantin_Neuraxpharm_outer_odt_cv_20170907_renewal
Date of last change:2017/09/07
Final Labelling
|
DE_3650_Memantin Aristo_outer_fct_cv_20170907_renewal
Date of last change:2017/09/07
Final Labelling
|
DE_3650_Memantin Aristo_outer_oso_cv_20170907_renewal
Date of last change:2017/09/07
Final Labelling
|
DE_5051_Memantin_Neuraxpharm_impack_odt_cv_20170907_renewal
Date of last change:2017/09/07
Final Labelling
|
DE_3650_Memantin Aristo_outer_initiation_cv_20170907_renewal
Date of last change:2017/09/07
Final Labelling
|
DE_3650_Memantin Aristo_inner_oso_cv_20170907_renewal
Date of last change:2017/09/07
Final Labelling
|
DE_3650_Memantin Aristo_bl_initiation_20170907_renewal
Date of last change:2017/09/07
Final Labelling
|
DE_3649_Memantin_Neuraxpharm_blister_fcte_cv_20170907_renewal
Date of last change:2017/09/07
Final Labelling
|
DE_3649_Memantin_Neuraxpharm_inner_oso_cv_20170907_renewal
Date of last change:2017/09/07
Final Labelling
|
DE_3649_Memantin_Neuraxpharm_outer_oso_cv__20170907_renewal
Date of last change:2017/09/07
Final Labelling
|
DE_3649_Memantin_Neuraxpharm_outer_fct_cv_20170907_renewal
Date of last change:2017/09/07
Final PL
|
DE_3650_Memantin Aristo_pl_fct_cv_20170907_renewal
Date of last change:2017/09/07
Final PL
|
DE_3650_Memantin Aristo_pl_initiation_cv_20170907_renewal
Date of last change:2017/09/07
Final PL
|
DE_5051_Memantin_Neuraxpharm_pl_memantin_odt_cv_20170907_renewal
Date of last change:2017/09/07
Final PL
|
DE_3650_Memantin Aristo_pl_oso_cv_20170907_renewal
Date of last change:2017/09/07
Final PL
|
DE_3649_Memantin_Neuraxpharm_pl_oso_cv_20170907_renewal
Date of last change:2017/09/07
Final PL
|
DE_3649_Memantin_Neuraxpharm_pl_fct_cv_20170907_renewal
Date of last change:2017/09/07
Final SPC
|
DE_3650_Memantin Aristo_spc_initiation-cv_20170907_renewal
Date of last change:2017/09/07
Final SPC
|
DE_5051_Memantin_Neuraxpharm_spc_memantin_odt_cv_20170907_renewal
Date of last change:2017/09/07
Final SPC
|
DE_3650_Memantin Aristo_spc_oso_cv_20170907_renewal
Date of last change:2017/09/07
Final SPC
|
DE_3650_Memantin Aristo_spc_fct_cv_20170907_renewal
Date of last change:2017/09/07
Final SPC
|
DE_3649_Memantin_Neuraxpharm_spc_fct_cv_20170907_renewal
Date of last change:2017/09/07
Final SPC
|
DE_3649_Memantin_Neuraxpharm_spc_oso_cv_20170907_renewal
Date of last change:2017/09/07
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase